Literature DB >> 3697513

Response to endocrine therapy and breast cancer differentiation.

J R Masters, R R Millis, R D Rubens.   

Abstract

The purpose of this study was to determine whether aspects of tumour differentiation are associated with response to endocrine therapy in patients with advanced breast cancer. The features studied were the histological type, grade, and elastosis content of the primary tumours, and the disease-free interval. Statistically significant associations were observed between response to endocrine therapy and histological grade and disease-free interval. In addition, statistically significant associations were observed between histological grade and elastosis and disease-free interval. It is concluded that tumours which are more highly differentiated have a better chance of responding to endocrine therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3697513     DOI: 10.1007/bf01886733

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Assessment of response and recurrence in breast cancer.

Authors:  J L Hayward; J W Meakin; H J Stewart
Journal:  Semin Oncol       Date:  1978-12       Impact factor: 4.929

2.  Elastosis in breast cancer.

Authors:  J G Azzopardi; R N Laurini
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

3.  Impact of tumor grade and host resistance on survival of women with breast cancer.

Authors:  H J Bloom; J R Field
Journal:  Cancer       Date:  1971-12       Impact factor: 6.860

4.  Histological grade and response to endocrine therapy in breast cancer.

Authors:  R R Millis; R D Rubens; J R Masters; M J Minton
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

5.  Correlation of hormone receptors with pathological features in human breast cancer.

Authors:  R R Millis
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

6.  Estrogen and progesterone receptors in breast cancer in Black Americans: Correlation of receptor data with tumor differentiation.

Authors:  S Mohla; C C Sampson; T Khan; J P Enterline; L Leffall; J E White
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

7.  Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis.

Authors:  J Stewart; R King; J Hayward; R Rubens
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

8.  Correlation of primary breast cancer histopathology and estrogen receptor content.

Authors:  E R Fisher; C K Osborne; W L McGuire; C Redmond; W A Knight; B Fisher; G Bannayan; A Walder; E J Gregory; A Jacobsen; D M Queen; D E Bennett; H C Ford
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

9.  Pathologic types of breast cancer: their prognoses.

Authors:  H S Gallager
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

10.  Elastosis and response to endocrine therapy in human breast cancer.

Authors:  J R Masters; R R Millis; R J King; R D Rubens
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

View more
  3 in total

1.  Histological grade in predicting response to endocrine treatment.

Authors:  M R Williams; R W Blamey; J H Todd; C W Elston; R I Nicholson
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

2.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

Authors:  M R Williams; J H Todd; I O Ellis; C S Dowle; J L Haybittle; C W Elston; R I Nicholson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

3.  Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer.

Authors:  J R Masters; R S Camplejohn; R R Millis; R D Rubens
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.